House passes “right-to-try” — allowing the terminally ill to ask companies for experimental drugs outside of FDA’s purview

The House on Tuesday afternoon passed a Senate-ratified version of a bill, known as “right-to-try,” and President Donald Trump has indicated he will sign it — further proof that the Koch brothers-backed Goldwater Institute’s politicization of the US Food and Drug Administration (FDA) is just beginning.